Press Release:

Horseracing Integrity and Safety Authority and Horseracing Integrity & Welfare Unit Recruiting Members for Internal Adjudication Panel

The Horseracing Integrity and Safety Authority (HISA) and Horseracing Integrity & Welfare Unit (HIWU) are accepting inquiries from individuals interested in serving on the Internal Adjudication Panel (IAP) established by HISA’s Anti-Doping and Medication Control (ADMC) Program, which goes into effect January 1, 2023.

Under the ADMC Program, members of the IAP will adjudicate Controlled Medication Rule Violations, which are defined inRule Series 3000: Equine Anti-Doping and Controlled Medication Protocol. They are appointed by mutual agreement of HISA and HIWU for four-year terms and will serve as independent contractors to both entities. The list of IAP members will be published on hiwu.org.

“Racing participants, fans, and bettors deserve a process for adjudicating potential violations of HISA’s medication rules that is uniform, efficient, and fair,” said HISA Chief Executive Officer Lisa Lazarus. “The creation of the IAP will allow us to bring seasoned experts together to ensure each case is handled with the utmost integrity and professionalism.”

“The IAP will play a key role in ensuring that Controlled Medication Rule Violations are adjudicated swiftly and fairly under HISA’s ADMC Program,” said Ben Mosier, executive director for HIWU. “Our goal is to compile a diverse and experienced group to handle these cases and promote the integrity of Thoroughbred racing.”

Interested candidates should have at least five years of experience in hearing equine medication cases, either as stewards or in other regulatory roles in the equine industry. Active state stewards are permitted to serve on the IAP but will be prohibited from participating in cases originating in their state of employment. Those selected as IAP members will receive training on the ADMC Program before they are assigned to cases.

Additional information about requirements for service on the IAP and adjudication procedures for Controlled Medication Rule Violations can be found in the Rule 7000 Series: Arbitration Procedures from HISA’s ADMC Program regulations that were submitted to the Federal Trade Commission.

Those who are interested in applying for the IAP should submit a cover letter, resume, and list of references to[email protected] with a subject line of “Internal Adjudication Panel.”

About the Horseracing Integrity and Safety Authority

Established when the Horseracing Integrity and Safety Act was signed into federal law in 2020, the Horseracing Integrity and Safety Authority (HISA) is responsible for drafting and enforcing uniform safety and integrity rules in Thoroughbred racing in the U.S. Overseen by the Federal Trade Commission (FTC), HISA was created to implement, for the first time, a national, uniform set of rules applicable to every Thoroughbred racing participant and racetrack facility. HISA is composed of two programs: the Racetrack Safety Program, which went into effect on July 1, 2022, and the Anti-Doping and Medication Control (ADMC) Program, which goes into effect January 1, 2023.

About the Horseracing Integrity & Welfare Unit

The Horseracing Integrity & Welfare Unit (HIWU) was established in 2022 by Drug Free Sport International to administer the rules and enforcement mechanisms of the Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control (ADMC) Program. The ADMC Program, which will be effective as of January 1, 2023, will create a centralized testing and results management process and apply uniform penalties for violations efficiently and consistently across all American Thoroughbred racing jurisdictions that HISA governs. HIWU will oversee testing, educate stakeholders on the new program, accredit laboratories, investigate potential violations, and prosecute any such violations.

About Drug Free Sport International

Drug Free Sport International is a worldwide leader in the sport drug testing industry. Drug Free Sport International administers comprehensive drug testing programs, manages national and international collections, develops drug testing policies, and provides educational services to a wide range of professional and amateur athletics organizations around the world. Its highly educated, experienced, and diverse staff is committed to quality, technical innovation, and maintaining the most extensive network of highly trained and certified sport drug testing collectors in the industry.